Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues
12:40pm, Monday, 24'th Mar 2025
Penumbra expects to materially increase both revenues and profitability in the company's international business in the next few years.
Growing Thrombectomy Business Supports PEN Stock, Macro Issues Ail
12:20pm, Friday, 28'th Feb 2025
Penumbra is still in the early stages of its journey to bring the company's proprietary thrombectomy technologies to patients in the United States and around internationally.
Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
04:05pm, Friday, 21'st Feb 2025
ALAMEDA, Calif. , Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassing has not
Penumbra (PEN) Upgraded to Buy: Here's Why
01:00pm, Thursday, 20'th Feb 2025
Penumbra (PEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Penumbra Q4 Earnings & Revenues Top, Margins Expand, Stock Rises
08:16am, Wednesday, 19'th Feb 2025
Penumbra reports better-than-expected earnings and revenues in the fourth quarter of 2024.
Penumbra, Inc. (PEN) Q4 2024 Earnings Call Transcript
11:04pm, Tuesday, 18'th Feb 2025
Penumbra, Inc. (NYSE:PEN ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser -
Here's What Key Metrics Tell Us About Penumbra (PEN) Q4 Earnings
07:01pm, Tuesday, 18'th Feb 2025
The headline numbers for Penumbra (PEN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates
06:20pm, Tuesday, 18'th Feb 2025
Penumbra (PEN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.76 per share a year ago.
Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
04:05pm, Tuesday, 18'th Feb 2025
ALAMEDA, Calif. , Feb. 18, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended Decem
Should You Add Penumbra Stock to Your Portfolio Right Now?
07:36am, Wednesday, 12'th Feb 2025
PEN continues to attract investor interest with its strong portfolio expansion and global expansion efforts.
Penumbra, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for February 18, 2025
04:30pm, Tuesday, 21'st Jan 2025
ALAMEDA, Calif. , Jan. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the fourth quarter and full year 2024 af
Buy 4 Low-Beta Stocks AVO, TXO, PEN & STRA to Beat Market Volatility
03:46pm, Friday, 17'th Jan 2025
It is imperative to build a portfolio of low-beta stocks to navigate a volatile market. AVO, TXO, PEN & STRA are well-poised to gain.
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
01:46pm, Thursday, 16'th Jan 2025
Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
08:51am, Wednesday, 15'th Jan 2025
Invest in companies like YPF, TEF, PEN, DECK and ANF to make the most of higher efficiency levels.
Penumbra (PEN) Surges 6.3%: Is This an Indication of Further Gains?
06:10am, Wednesday, 08'th Jan 2025
Penumbra (PEN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
